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The physiological
sites and mechanisms
involved
in the
homeostatic
regulation
of plasma
protein
turnover
are as yet
poorly
understood.
The role of prosthetic
oligosaccharides
as
regulatory
determinants
for the catabolism
of circulating
glycoproteins
has received
much attention,
however,
since the
pioneering
investigations
of Ashwell,
Morell,
and co-workers
(2); They
demonstrated
that
in vitro
modifications
of the
oligosaccharides
of several
plasma
glycoproteins
can produce
significant
alterations
in their circulating
half-life,
and have
described
a mechanism
for the rapid
hepatic
catabolism
of
plasma
asialo-(P-galactoside
terminal)glycoproteins.
More
recent reports
have indicated
(3-5) that further
degradation
of
plasma
protein
oligosaccharides,
resulting
in exposure
of
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internal
/3-N-acetylglucosaminyl
and core cu-mannosyl
residues, might
also trigger
the rapid
clearance
of these glycoproteins
from the circulation.
However,
the extent
to which
these carbohydrate-specific
clearance
processes
are involved
in
the in uiuo regulation
of plasma
glycoprotein
metabolsim
is
still unclear.
While
the previous
studies
have focused
on the effects
of
partially
degraded
oligosaccharides
on the catabolism
of glycoproteins,
the goal of the present
study was to assess the overall
effect of the complete,
native
oligosaccharide
component
on
glycoprotein
metabolism.
To achieve
this goal we required
a
system in which the specific
contribution
of the oligosaccharide
prosthetic
group
and the apoprotein
component
could
be
separately
evaluated.
Fortunately,
nature
has provided
such
a system,
in the form of the four bovine pancreatic
ribonuclease
(RNase)
isozymes.
These isozymes,
described
by Plummer
and
Hirs (6, 7), consist
of the same polypeptide
chain,
and differ
only in their degree
of glycosylation
at asparagine
residue
34:
RNase’
A is the unglycosylated
“aglycone”;
RNase
B has the
‘The abbreviations
used
clease;
DFP,
diisopropyl
insolubilized.
aparose-bound
isozyme specifically
prepared

are: RNase. bovine pancreatic
ribonuphosphorofluoridate;Con
A-agarose,
concanavalin
A; RNase B”, RNase B
from commercial
RNase B (Sigma type
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The circulating
half-lives
of the four isozymes
of bovine
pancreatic
ribonuclease
(RNases
A, B, C, and
D) have been determined
in normal
and in nephrectomized
rats. The isozymes
differ only in their glycosyl
content.
While A contains
no sugars, B has a simple oligosaccharide
(GlcNAc,
Man,+),
and C and D each
have a complex
oligosaccharide
(GlcNAc,
Man,.,
Gal, Fuc NeuAc%,
and GlcNAc,
Mans
Gal,
Fuc
NeuAc,,
respectively)
attached
to Asn-34 of the polypeptide
chain. All four isozymes
were cleared
rapidly
in normal
rats (t,,,
= 2 to 3 min),
as expected
on the basis of the established
role of the kidneys
in
removing
low molecular
weight
proteins
from
circulation.
In nephrectomized
rats, however,
a much
slower clearance
was observed,
thus permitting
the evaluation
of the role of the carbohydrate
chains
in
the catabolism
of the isozymes.
The clearance
curves can be analyzed
in terms of two processes,
a rapid
initial
one, shown to represent
the equilibration
of the injected
enzyme
into extravascular
space, and a
second one which
is interpreted
as the catabolic
clearance
of the enzyme.
The half-life
of the RNase
isozymes
was calculated
from this second process and found to be in the range 528 to 577 min for RNase
A, 15 min for RNase B, 681 to 862 min for RNase
C, and 839 to 941 min for RNase
D. The rapidly
cleared
RNase
B was treated
with cu-mannosidase
to remove
3 of the 4 mannosyl
residues,
leaving
only a
trisaccharide
(GlcNAc,-PMan)
attached
to the protein.
The half-life
of this RNase
B derivative
was
found to be in the range 616 to 733 min. From these results it is concluded
(a) that the addition
of complex
oligosaccharides
to a protein
does not have any significant
direct effect on its circulating
half-life
(RNases
C and D compared
to RNase
A), and (b) that
in the rat there
exists
a mechanism
for clearing
glycoproteins
based on specific
recognition
of exposed
oc-mannosyl
residues
(RNase
B compared
to the
other isozymes
and to cY-mannosidase-treated
RNase B).

Circulating

Ijalf-life

of RNases A, B, C, and D

characteristic,
simple
plasma-type
oligosaccharide
side chain
containing
only mannose
and N-acetylglucosamine;
RNases
C
and D have complex
plasma-type
oligosaccharides
containing
galactose,
fucose,
and sialic
acid,
as well as mannose
and
N-acetylglucosamine.
These isozymes
of RNase are identical
in
amino
acid composition,
ultraviolet
absorption
spectra,
and
specific
enzymatic
activity,
with tryptic
peptide
maps indicating that they have identical
amino
acid sequences
(8). Thus,
comparing
the in uiuo plasma
half-lives
of the various
glycoprotein isozymes
of RNase to the half-life
of the aglycone
RNase A
it is possible
to evaluate
directly
the effect of glycosylation
on
the plasma
survival
time of a polypeptide
chain.
MATERIALS

AND

METHODS

Assays-RNase
activity
was determined
using either cytidine 2’:3’-phosphate
(9) or yeast RNA as substrate.
Assays using RNA
substrate
were performed
by a modification
of the procedure
of
Anfinsen et al. (10). RNase (0 to 100 ng) was added to 0.05 ml of 0.1 M
Tris.HCl,
pH 7.4, which contained
1 M NaCl, and 0.2 mg/ml of bovine
serum albumin
to prevent
adsorption
of the enzyme on glass. The
reaction was started by addition
of 1 ml of 8 mg/ml of RNA in 0.1 M
Tris.HCl,
pH 7.4, incubated
for 20 min at room temperature,
and
stopped
by addition
of 1 ml of 1.25% many1
acetate
in 12.5%
trichloroacetic
acid. Following
centrifugation,
0.5 ml of supernatant
was diluted to 2.5 ml with water, and the absorbance
at 260 nm was
determined.
RNase A (Sigma, type lA), purified
by ion exchange on
IRC-50 according
to Hirs et al. (ll),
was used as the standard
for
estimation
of RNase concentration.
Protein
and Amino
Acid
Determinations-Protein
concentration
during RNase purification
was estimated
from absorbancy
measurements, using an absorbance
(280 nm) of 18 for a 1% solution
of
unfractionated
pancreatic
juice (12). Protein
concentration
in the
purified RNase isozyme preparations
was determined
from amino acid
analyses. Amino acid analyses were performed
on the Beckman
model
119 amino acid analyzer.
Samples were adjusted to approximately
0.5
mg of protein/ml
of 6 N HCl, and hydrolyzed
in evacuated,
sealed
ampoules for 24 h at 110”.
Carbohydrate
Analyses
of RNase
Isozynes-Neutral
sugars were
estimated
on a Technicon
carbohydrate
analyzer
according
to Lee et
al. (13, 14), following
hydrolysis
of 0.5 mg of protein/ml
of 2 N
trifluoroacetic
acid for 4 h at 100”. Glucosamine
was estimated
with
the amino acid analyzer
following hydrolysis
of 0.5 mg/ml of 3 N HCl
for 9 h at 110”. Corrections
for destruction
of carbohydrates
during
hydrolysis
were estimated
from hydrolyses
of known
amounts
of
monosaccharides
in the presence of RNase A. Sialic acid was determined by the thiobarbituric
acid method of Warren
(15) following
hydrolysis
of protein in 0.1 N H,SO, for 1 h at 80”.
Disc Gel Electrophoresis-Electrophoresis
of RNase isozymes was
carried out at pH 4.0, in 15% cross-linked
polyacrylamide
gels for 6 h at
5 mA per gel according to McAllister
et al. (16).
Purification
of RNase
Isozymes-Bovine
pancreatic
juice
was
obtained by pancreatic
duct cannulation,’
according to the method of
Wass (17). Secretions were collected in iced containers changed at 12-h
intervals,
DFP (1 M in isopropanol)
was added to a final concentration
of 5 x lo-’ M, and the juice was lyophilized.
The resulting powder was
stored at -20”. RNase activity
was found to be stable for at least 3
months under these conditions.
All purification
steps were carried out
at 4’.
The lyophilized
pancreatic
juice powder was dissolved with stirring
in distilled
water (lo%, w/v), and DFP was added to 1 mM final
concentration.
The solution was dialyzed
in a Bio-Rad
Bio-Fiber-50
beaker against 0.2 M sodium acetate buffer, pH 5.2, until chloride ion
was no longer detectable
in the dialysate
by titration
with 0.1 M
AgNO,. Precipitated
protein was removed by centrifugation
for 10 min
at 12,000 x g. If necessary, the pH was adjusted to pH 5.2 with a few
Enzyme

drops of 1 M acetic acid. This solution was then applied to the RNase
affinity
column
prepared
by coupling
N’-(6-aminohexyb-cytidine
2’(3’)-monophosphoric
acid to activated
CH-Sepharose
4B (Pharmacia) according to the procedure of Scofield et ~l.~RNase
was applied
at a level of 4 to 5 mg/ml of column volume, and was quantitatively
adsorbed
to the column under these conditions.
The column was
washed with 3 to 4 bed volumes of 0.2 M sodium acetate, pH 5.2, and
then eluted with 4 M NaCl in the same buffer. More than 98% of the
RNase was recovered in the eluate, resulting typically
(see Fig. 1) in an
8 to 12-fold purification.
At this point the RNase was approximately
25
to 30% pure. Elution of the affinity column with a gradient of NaCl in
acetate buffer did not yield a significant
improvement
in purification.
RNase-containing
fractions were pooled and adjusted to pH 3.5 with
4 M HCl (7). After 1 h the mixture was centrifuged
for 10 min at 12,000
x g; the precipitate
was washed with 5 volumes of 0.2 M acetic acid and
discarded.
The pH 3.5 precipitation
usually resulted in only about a
20% increase in purity with 90 to 95% yield. This step was included in
the purification
scheme, however, because it removed materials which
otherwise
precipitated
during
the subsequent
dialysis
and which
tended to co-precipitate
significant
amounts of RNase.
The pH 3.5 supernatant
and the acetic acid wash were pooled, and
dialyzed in the Bio-Fiber
device against 0.01 M Tris.HCl,
pH 7.0. The
progress of the dialysis
was followed
by monitoring
the electrical
conductivity
of the dialysate.
DFP was added to the dialysand
(final
concentration,
1 mM), and, if necessary,
the pH was adjusted to 7.0
with a few drops of 1 M Tris base. In order to separate the RNase
isozymes this solution
was chromatographed
on CM-cellulose
(-500
mg RNase on a 2 x 12 cm column), using a l-liter gradient of 0 to 0.15 M
NaCl in 0.01 M Tris.HCl,
pH 7.0. The elution profile of enzymatic
activity
on the CM-cellulose
column was essentially
identical
to that
shown in Ref. 7. Based on this elution profile the isozyme composition
of the pancreatic
juice was found to be 94% RNase A, 5% RNase B,
0.7% RNase C, and 0.5% RNase D.
The RNase-containing
fractions
corresponding
to RNase B, and
C + D were pooled from several column runs for further purification.
Only RNases B, C, and D were purified
from pancreatic
juice. The
fraction
corresponding
to RNase A was not processed further.
The
RNase A used as the enzyme standard
and for injection experiments
was the repurified
commercial
RNase A (Sigma type IA).
To remove contaminating
RNase A, the pooled RNase B peak was
chromatographed
on a column of Con A-agarose (Sigma).
The RNase
A passed through
the column unretarded
while RNase B was bound
selectively
(cf. Fig. 2a), and was eluted
with 10% a-methyl-oglucopyranoside.
The column capacity
was approximately
1.3 mg of
RNase B/ml of gel volume of a Con A-agarose gel rated at 3.7 mg of
3R. E. Scofield,
publication.

R.

P. Werner,

and

F. Wold,

submitted

for
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XII-B);
RNase B’, the product of cu-mannosidase
digestion of RNase
B’.
*The authors wish to express their appreciation
to Dr. D. E. Otterby
and Mr. S. A. Nelson,
of the Department
of Animal
Science,
University
of Minnesota
for donating
and caring for the animals used
in this study, and to Dr. E. A. Usenik,
Department
of Surgery,
University
of Minnesota
School of Veterinary
Medicine,
for performing
the pancreatic
duct cannulations.

FIG. 1. Chromatography
of pancreatic
juice on RNase affinity
column. Lyophilized
pancreatic
juice powder (16 g total weight, 6 g of
protein),
containing
170 mg of RNase activity
in 280 ml of 0.2 M
sodium acetate, pH 5.2, was chromatographed
on a 40-ml (2 x 13 cm)
RNase affinity column. Elution
with 4 M NaCl resulted in recovery of
168 mg of RNase, with Il-fold purification.
Fraction volume: 7 to 8 ml.
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FIG. 2. Chromatography
of RNase isozymes on Con A-agarose.
a,
samples of 50 pg of the purified RNase isozymes were dissolved in 250
~1 of 0.1 N Tris.HCl,
pH 7.4, containing
1 M NaCl, 1 mM CaCl,, MgCl,,
and MnCl,,
and applied to a l-ml Con A-agarose column prepared
in
a disposable pipette. The column was eluted at the rate of 1 ml (1 bed
volume) per 10 min, and l-ml fractions were collected. After 40 column
volumes
of the starting
buffer,
the column
was eluted with 10%
a-methyl-n-glucopyranoside
in the same buffer. Elution
profiles for
RNases C and D varied with the amount of enzyme and rate of elution,
but complete elution of these isozymes required
10 to 20 volumes of
buffer. b, 100 mg of commercial
RNase B (Sigma type XII-B)
was
dissolved in 10 ml of above buffer, and applied to a 15-ml (2 x 5 cm)
Con A-agarose
column.
Fractions
of 5 ml were collected;
the arrow
marks the beginning of elution with 10% or-methyl-n-glucopyranoside.
Recovery
was greater than 98%. On five separate applications
19 to
21% of RNase activity
was eluted by a-methyl-n-glucopyranoside.
yeast mannan/ml.
The RNase B pool from the lectin column was
finally rechromatographed
on the RNase affinity column as described
previously.
The pooled RNase C + D peak from the CM-cellulose
column was also rechromatographed
on the RNase affinity
column.
RNase C and D isozymes were then separated
by chromatography
on
CM-cellulose
in a l-liter gradient of 0.02 to 0.075 M NaCl in 0.01 Tris.
HCl, pH 7.0. RNase C was further purified by isolation of the fraction
retarded
on Con A-agarose (Fig. Za).
Since the commercial
product was a more convenient
source of the
RNase B isozyme,
Sigma RNase B (type XII-B)
was purified
by
chromatography
on Con A-agarose
as shown in Fig. 26. The fraction
which was bound by the lectin column and was eluted by a-methyl-nglucopyranoside,
accounted for about 20% of the commercial
RNase B
applied to the column, and was termed RNase Be. The remaining
80%
of the commercial
RNase B was eluted in the void volume of the
column, and did not contain carbohydrate.
The heterogeneity
of the
commercial
RNase B, and its separation
into two components
by
chromatography
on Con A-agarose is verified in the disc gel electrophoresis patterns shown in Fig. 3~.
Glycosidase
Dzgestzon
of RNase B”-Jack
bean a-mannosidase,
kindly provided
by Dr. Gary Nelsestuen
(University
of Minnesota),
had
a specific activity
of 30 rmol of p-nitrophenyl-cu-nmannopyranoside
hydrolyzed
per min at 37” per mg of protein. This enzyme had no detectable
@-N:acetylglucosaminidase
or 6-mannosidase
(<O.Ol%)
activity
using p-nitrophenylglycosides
as substrates.
a-Mannosidase
(0.3 unit) was added to 12.5 mg of RNase B’ in 5 ml of 0.1 N sodium
acetate, pH 5.0, containing
1 mM ZnSO, (37’). An additional
0.3 unit of
cu-mannosidase
were added at 12 and 24 h. Aliquots (0.1 ml) were removed at various times, and assayed for mannose
released by a
coupled
hexokinase/pyruvate
kinase/lactate
dehydrogenase
system,
according
to Tarentino
et al. (18). The mannose release leveled off after 36 h, at which time a total of 3.1 mol of mannose had been removed

TABLE I
composition
of ribonuclease

Carbohydrate
For comparable

data.

isozymes

see Ref. 7.

Ribonuclease
lsozyme

A

B’

Glucosamine
Mannose
Galactose
Sialic acid
Fucose

0
0
0
0
0

1.9
4.7
0
0
Tr

B”

B

mol carbohydratelmol

1.8
1.0
0
0
0

C

D

4.1
2.6
2.0
2.2
1.0

3.9
2.9
1.9
4.0
1.1

protein

2.0
4.3
Tr”
0
Tr

cITr, trace.
per mol of RNase B’. At 36 h a sample of the digestion mixture was applied to the carbohydrate
analyzer,
and 3.0 mol of free mannose were
detected
per mol of RNase Be. The product
of this ol-mannosidase
digestion of RNase B’ was isolated by Sephadex G-75 chromatography
and is referred to as RNase B’. Carbohydrate
analyses indicated
that
RNase Bx contained
2 N-acetylglucosamine
and 1 mannose residue.
Based on the structural
analysis of Sukeno et al. (19), the residual
mannose in &linked
to an N-acetylglucosamine
residue, thus explaining its resistance to Lu-mannosidase.
Characterization
of RNase Isozymes-Table
I shows the carbohydrate composition
of the RNase isozymes used in this study. These
data are in good agreement
with those previously
published
by
Plummer
and Hirs (6, 7). The homogeneity
of the isozymes
is
supported
by the electrophoretic
patterns shown in Fig. 3b in which
each isozyme yields a single band of staining
material
with a distinct
electrophoretic
mobility.
RNase B, prepared
from pancreatic
juice,
and RNase
B’, prepared
from the commercial
product,
behave
identically
on disc gel electrophoresis,
consistent with the similarity
in
their carbohydrate
composition.
When chromatographed
on Sephadex
G-75 each isozyme yielded
a single peak of protein and enzymatic
activity,
eluting at a volume corresponding
to the monomeric
form of
the enzyme; there was no evidence of aggregation.
The relative specific
activity
of the various
isozymes,
using cytidine
2’:3’-phosphate
as
substrate,
was: A = 100, B = 96, Be = 96, B’ = 93, C = 94, D = 98.
Using RNA as substrate,
the relative specific activities
were: A = 100,
B = 84, B’ = 78, B” = 80, C = 78, D = 77. From a comparison
of the
relative specific activities
using the two different substrates,
it appears
that the oligosaccharide
in the glycoprotein
isozymes causes a slight
inhibition
of the activity
of RNase toward the macromolecular
RNA
substrate.
Preparation
and Sizing of Fluorescein-labeled
Dextrun-Dextran
T-10 (Sigma) was reacted with fluorescein
isothiocyanate
according to
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FIG. 3. Polyacrylamide
disc gel electrophoresis
of RNase isozymes.
Protein samples (15 to 20 fig) were electrophoresed
as described under
“Materials
and Methods.”
a, Lane I, RNase A; 2, Sigma type XII-B
RNase B, showing approximately
4:l ratio of two components;
3, the
component
which is not retarded
on Con A-agarose;
4, RNase B’, the
component
eluted from Con A-agarose with cY-methyl-n-glucopyranoside; 5, mixture of equal amounts of each component.
b, Lane I, RNase
A; 2, RNase Be; 3, RNase B’; 4, RNase B; 5, RNase C; 6, RNase D; 7, a
‘mixture
of equal amounts of RNases A, B, C, and D.

Circulating

Half-life

of RNases A, B, C, and D

FRACTION

the method of deBelder
and Granath
(20), using dibutyltin
dilaurate
(Ventron/Alfa)
as catalyst.
The product
was washed three times by
precipitation
with ethanol, then dissolved in distilled
water (5% w/v)
and dialyzed
overnight
against 100 volumes of distilled
water. The
dialysand was lyophilized,
redissolved
in 0.2 M ammonium
acetate (5%
w/v), and chromatographed
on a calibrated
Sephadex G-75 column in
the same buffer (Fig. 4a). Fractions
40 to 43, corresponding
to the
elution volume of RNase A, were pooled and lyophilized.
A mixture
of
RNase A and the sized dextran derivative
was chromatographed
on the
same G-75 column to show that the collected fraction of dextran
was
similar in molecular
size to RNase A (Fig. 46). In addition,
[“Clinulin
(New England
Nuclear,
Inulin-carboxyl,
[carboxyl-“Clinulin,
19.3
mCi/g), A4, = 5500, was also chromatographed
in the same column run
to verify its molecular
size and the absence of low molecular
weight
degradation
products;
the data for the [“Clinulin
is shown here since
the [“Clinulin
and fluorescein/dextran
are used later in the same
experiment
(Fig. 7).
Animal Experiments-Experiments
were performed
using normal or
nephrectomized
male albino rats weighing
300 to 360 g. Bilateral
nephrectomies
were performed
under ether anesthesia
through
a
midline
incision.
The renal vein and artery,
and the ureter were
ligated, and the kidneys were excised. The incision was sutured,
and
the animal was allowed to recover for 6 to 12 h. Ribonuclease
isozymes
(500 pg) were injected intracardially
in 100 to 500 ~1 of physiological
saline. Blood samples (75 ~1) were obtained
at timed intervals
from
lateral tail veins. The first sample was generally
taken at 100 s after
injection.
Blood was collected
in heparin-treated
capillary
pipettes,
and plasma was separated by centrifugation.
Aliquots of plasma (3 ~1)
were assayed in duplicate
for RNase activity.
Endogenous
activity
in
both normal and nephrectomized
rats was 0.6 * 0.2 fig of RNase/ml
of
plasma.
RESULTS

RNase
A, RNase
B, and a 1:l mixture
of RNase
C and D
were injected
separately
into normal
rats. The data in Fig. 5
show that
all of the isozymes
are rapidly
cleared
from
the
plasma
with
half-lives
of 2 to 3 min. These
results
confirm
previous
reports
on the rapid clearance
of RNase
A in the rat
(22-24),
and also establish
that the carbohydrate
prosthetic
groups
on RNases
B, C, and D do not significantly
alter the
rate of clearance
of these isozymes
in the normal
rat.
The site of RNase
clearance
has been localized
primarily
in
the kidney
(22-26),
and reflects
the major role for this organ in
the catabolism
of proteins
of molecular
weight
lower
than

NUMBER

spectrophotometer.
Fractions
40 to 43, corresponding
in size to RNase
A, were pooled. b, co-chromatography
of pooled fluorescein/dextran
(0.1 mg), RNase A (0.1 mg), and [“Clinulin
(0.1 pCi) under above
conditions.
Aliquots
of each fraction
were assayed for fluorescence,
enzyme activity,
and radioactivity.

IL
0

I
200

400

I

8
600

000

TIME (4

FIG.
RNase
two or
through
RNase

5. Clearance
of RNase isozymes from plasma of normal rats.
isozymes (500 rg) were injected into weight-matched
groups of
three rats. Half-lives
are calculated
from least squares fit
all points on lines drawn in figure. a, RNase A, t,,, = 155 s; b,
Be, t 1,2 = 132 s; c, mixture of RNase C + D (l:l), t,,, = 149 s.

albumin
(27, 28) which
can readily
permeate
the glomerular
basement
membrane.
Because
the rapid,
nonspecific
renal
clearance
of RNase
could
prevent
the observation
of other
clearance
mechanisms
operating
specifically
on the plasma
proteins,
all subsequent
experiments
were
performed
with
nephrectomized
rats.
Fig.
6 shows
the results
of injection
of RNase
A into
nephrectomized
rats. The clearance
curve is complex,
consist-
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FIG. 4. Molecular
sizing of fluorescein-labeled
dextran,
RNase, and
inulin. a, fluorescein/dextran
(100 mg) was dissolved in 1 ml of 0.2 M
ammonium
acetate and chromatographed
on a column (1 x 35 cm) of
Sephadex
G-75. Fractions
of 0.5 ml were collected.
Aliquots
were
assayed for anthrone
reactivity
(21), and fluorescence
at 518 nm
(excitation
493 nm) on a Hitachi
Perkin-Elmer
MPF-2A
fluorescence

6019

6020

Circulating

Half-life

of RNasesA, B, C, and D

2
0

200

400
TIME

600

(mm)

FIG. 6. Clearance of RNase A from plasma of nephrectomized rats.
RNase A (500 rg) was injected into three rats, and half-lives were
estimated as 528 (O), 537 (A), and 577 (0) min, respectively, from the
least squares fit through points at times greater than 100 min.

lRNase] = C,e-bl’ + C,e-b*’
where [RNase] is the plasma RNase concentration; and C, and
C, are the intercepts, and b, and b, the slopes of the rapid and
slow processes, respectively. According to Sterling (29, 31) the
intercept, C1, can be considered to represent the hypothetical
concentration of the substance at zero time after equilibration
with extravascular space (EVS), and the intercept, C,, to

FIG. 7. Comparison of clearance kinetics for RNase A, fluorescein-labeled dextran (HZ’C), and [“C]inulin. A mixture of RNase A (500 rg),
dextran (2 mp), and 1”Clinulin (10 UCi) in 0.4 ml of physiological
saline was injected into a 350-g nephrectomized rat. Data is shown as
per cent of 100-s time point which contained 34.4 pg of RNase/ml, and
1550 cpm of “C per 10 pl. The C, intercept on the inulin curve is higher
than the RNase and dextran curues, reflecting the more rapid rate of
inulin (M, - 5500) equilibration into extravascular compartments.
The C, and C, intercepts for RNase A were at 105 and 23%
respectively, and for dextran, 109 and 21%. The half-life of RNase A in
this experiment was 5.6 and 540 min for the first and second phases,
respectively, and, for fluorescein-labeled dextran, 5.0 and 360 min.

represent the concentration
of a substance that would have
existed in the plasma volume (Pl) at zero time if no equilibration had taken place. Then, the approximate ratio of compartment sizes can be estimated from the equation:
Cl
_=c,

EVS
Pl

Computed in this manner, the ratio of compartment
sizes
(EVS/Pl) for RNase A is 4.6, and for the sized dextran, 5.2
(data in legend to Fig. 7). From the similarities in the kinetics
of clearance, and the C,and C, intercepts for the RNase and
dextran curves, it appears that these molecules are equilibrating not only at the same rate but also in the same ratio into
plasma and extravascular compartments. From the data in this
and the other experiments (cf. Figs. 6 and 8), the extravascular
compartment
appears to be about 4.5 to 5.5 times as large as
the plasma compartment for a molecule of the size of RNase A.
The total volume, VT, into which the injected material is
distributed can be independently estimated from the quantity
injected (Q) and the concentration
at C, (after equilibration,
but before clearance), i.e.
-

Q = VT = Pl + EVS.
C2

In the experiment in Fig. 7, the injection of 500 pg of RNase
produced a C, intercept of 7.5 pg of RNase/ml of plasma (cf.
Fig. 7 legend), which yields a total distribution
volume, VT =
67 ml for RNase A. An independent
estimate of VT was
obtained by simultaneously
injecting 10 &i of [“Clinulin,
resulting in VT = 63 ml for inulin. The estimated VT for
dextran was 49 ml, but this is probably the least accurate VT
estimate since serum proteins altered the dextran’s fluorescence and thus introduced uncertainties in the estimates of Q.
The data obtained with RNase A and [“Clinulin
in a 350-g rat,
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ing of a rapid, initial decline, followed by a slower first order
clearance process, as is frequently observed in enzyme injection
experiments (29, 30). The first phase is generally attributed to
diffusion and equilibration
of the enzyme into extravascular
compartments,
and the second, slower phase results from
catabolic clearance of the enzyme from the circulation. A least
squares fit was calculated for the second phase of the decay
curve, and the slope, b,, and intercept, C,, were calculated.
The half-life of RNase A, (t,,, = 0.693/b,), was found to be 528,
537, and 577 min in three injection experiments.
Several lines of evidence suggest that the initial rapid
decline in plasma RNase resulted from an equilibration
process
rather than from a selective removal of a unique fraction of the
injected enzyme. Thus, no heterogeneity was detected in any of
the RNase samples by ion exchange chromatography
on
CM-cellulose or IRC-50, by gel permeation on Sephadex G-75
(Fig. 4), or by gel electrophoresis (Fig. 3). In addition, efforts to
detect a binding protein which might mediate the removal of a
fraction of the RNase as a complex were unsuccessful. No
inhibition
of RNase activity was observed upon mixing with
plasma, nor was the elution volume of RNase on Sephadex
G-75 altered after incubation with plasma.
In a more direct experiment to establish that the first phase
in the plasma decay curve resulted from an equilibration
process, the fluorescein-labeled
dextran with approximately
the same molecular size as RNase (Fig. 4) was injected
simultaneously with RNase A. As shown in Fig. 7 the kinetics
of the initial clearance of RNase A and the dextran derivative
are essentially identical, consistent with the hypothesis that
molecules of the same size should diffuse at identical rates into
extravascular compartments. The difference in the kinetics of
clearance during the second phase can be attributed
to
differential rates of catabolism of the RNase A and dextran.
Analysis of the decay curves shown in Fig. 7 permits an
estimate of the relative and absolute sizes of the plasma and
extravascular compartments. By the process of “curve peeling”
(29) the decay curves were described by the sum of two
exponential processes, e.g.
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FIG. 8. Clearance of RNases C and D from
rats. a, RNase C (500 pg) injections into three
half-lives
of 681 (O), 830 (A), and 862 (0)
injections yielded half-lives
of 839 (0), 859

plasma of nephrectomized
rats resulted in estimated
min. 6, RNase D (500 rg)
(A), and 941 (0) min.
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FIG. 9. Clearance of RNase B and B’ from plasma of nephrectomized
rats. Two animals were used for each isozyme (500 pg of RNase per
injection).
Black bar at lower left shows the range of background
activity
for these animals.
The line with tri = 15 min is a least
squares fit through
all points at less than 60 min, and is drawn as a
convenient
reference only; the slope of the clearance curve appears, in
fact, to be varying continuously
during the experiment.

indicate that the extracellular fluid volume is about 16 to 20%
of the body weight. These estimates are consistent with the
estimated plasma volume of 3% of the body weight in the rat
(32) and an extravascular compartment
of about 5 times the
plasma volume. These volumes and ratios may not, however,
represent the normal physiological situation in the rat since the
animals used in these experiments had been nephrectomized
6
to 12 h earlier.
Having established that the initial rapid clearance of RNase
from plasma is an equilibration
process, our attention was now
-I
20
24
28 focused on the second, slower phase which represents the
FRACTION
NUMBER
catabolic clearance of the molecule. Fig. 8, a and 6, shows the
FIG.
10.
Chromatography
of
RNase
B’ on Con A-agarose
before and
plasma decay curves for injections of RNases C and D. The
after a-mannosidase treatment. RNase B” was treated with a-manhalf-lives for RNase C in three rats were 681, 830, and 862 min,
nosidase as described under “Materials
and Methods.”
Aliquots
(100
and for RNase D in three rats 839, 859, and 941 min. In three rg) of the original RNase B”, and the product, RNase B’, were
other preliminary
experiments in which a partially purified
chromatographed
on l-ml columns of Con A-agarose as described in
Fig. 2a.
mixture of RNase C and D (pooled C + D peak from first
CM-cellulose fractionation)
were injected, the half-lives of the
product of the mannosidase digestion, RNase B”, was reisoC + D mixture were 691, 787 and 799 min. In all experiments
lated by chromatography
on Sephadex G-75. The purified
the half-lives of the RNase isozymes containing
complex
RNase B” was no longer bound by concanavalin A (Fig. 10); this
carbohydrates
(C and D) were 25 to 75% longer than the
is consistent with the fact that its a-mannosyl residues, the
half-life of RNase A. The half-lives of RNases C and D were not
recognition
site for binding to concanavalin
A, had been
significantly different from one another.
enzymatically
removed. Chemical analysis of RNase B” sugFig. 9 shows that, in contrast to RNases A, C, and D, RNase
B (Man) 1,
B and RNase B” are rapidly cleared from the circulation with a gests that its core trisaccharide (19), Asn-(GlcNAc),
is still intact.
half-life of approximately 15 min. At 3 h after the RNase B and
Fig. 11 depicts the results of injection experiments with
B’ injections the residual plasma RNase activity was generally
indistinguishable
from endogeneous levels, while levels of RNase B”. The rapid clearance characteristic of RNase B” was
RNase A, C, and D at this time consistently were at 5 to 10 not observed after removal of the a-mannosyl residues of the
simple oligosaccharide. The half-life of RNase B” in three rats
times the endogenous activity.
was 616,636, and 733 min, an average of about 20% longer than
Since the only difference between RNase B or B’ and the
that of RNase A.
other RNase isozymes is the presence of the simple oligosaccharide at Asn-34, it is reasonable to propose that this
DISCUSSION
oligosaccharide,
and specifically its terminal ol-mannosyl residues, might be involved in the rapid clearance of RNase B. To
Since the several isozymes of RNase differ only in their
test this proposal RNase B” was treated with jack bean
carbohydrate prosthetic group, the differences in the plasma
cr-mannosidase (see “Materials and Methods”) resulting in the
half-lives of these isozymes can be attributed to the influence
release of all but 1 mannose residue per RNase molecule. The
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FIG. 11. Clearance of RNase B’ from plasma of nephrectomized rats.
Three animals were injected with 500 ~cg of RNase B”, resulting in
estimated half-lives of 616 (A), 636 (0), and 733 (0) min. The kinetics
of clearance of the original RNase BC is shown (A- - -A) for
comparison.
TABLE

RNase

Isozyme

half&es

II

of RNase

isozymes
Measured

half-life
min

RNase A
RNase B
RNase B”
RNase B”
RNase C
RNase D

528,537,540,517

-15
-15
616,636,733
681,830,862
839,859,941

of the specific type of oligosaccharide
moiety in the isozyme.
The findings from the comparison of the half-life of the
isozymes are summarized in Table II and include two significant, new observations concerning the effect of glycosylation on
the plasma survival time of a protein. First, in comparison to
the nonglycosylated
protein the attachment
of a complex,
acidic oligosaccharide to the polypeptide chain results in only a
relatively small (175%) increase in the half-life of RNase in the
circulation.
Secondly, the attachment of a simple, neutral,
a-mannosyl-terminal
oligosaccharide
at the same site on the
same polypeptide
chain results in a significant, more than
30-fold decrease in its half-life in the circulation.
It seems unlikely that the major biological role for the
complex oligosaccharides is reflected in the slight increase in
half-life of RNases C and D as compared to RNase A. Indeed,
the increase in half-life of RNases C and D might be attributed
solely to the shift in the isoelectric point (~1) of RNase
produced by the 2 or 4 sialic acid residues at the end of the
oligosaccharide
chain. Rutter and Wade (33) and Holcenberg
et al. (34) have shown that the half-life of an enzyme in plasma
is closely related to its p1. Thus, one would predict that the
lowered p1 of RNases C and D relative to RNase A would be
adequate to explain their increased plasma half-life.
We consequently conclude that the intact complex oligosaccharide of the plasma glycoproteins may not directly affect the
rate of these protein’s catabolism in the circulation relative to
the corresponding
nonglycosylated
proteins. However, the
previous work which has clearly established hepatic removal of
asialo-(p-galactosyl-terminal)glycoproteins
from the mammalian circulation (2), and asialo-agalacto-(&N-acetylglucosaminyl-terminal)glycoproteins
from the avian circulation
(3),
leaves little doubt that the partially degraded, or incompletely
synthesized oligosaccharide
carries important
messages. The
messages in the cases studied to date appear to function in
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Plasma

restricting the site of catabolism of certain glycoproteins to the
liver. These proteins may normally be present in only trace
amounts in plasma, and Burger et al. (35, 36) have, for
example, presented evidence which indicates that the catabolism of transcobalamin
II specifically in the liver via the
Ashwell-Morel1
pathway might be involved in the regulation of
vitamin Blz homeostasis. At this stage it appears, therefore,
that the intact complex carbohydrate chain, which may not
itself affect the half-life of circulating glycoproteins, carries a
potential tissue-directing
signal, which must be uncovered by
alteration in its covalent structure before it can be read.
The results presented in this paper demonstrate that an
additional
“hidden”
signal in the RNase isozymes is specifically expressed by exposed, nonreducing terminal a-mannosyl
residues. When RNase A has been biologically modified by the
attachment of a simple oligosaccharide
to form RNase B, its
half-life in the circulation was found to be reduced by about
30-fold. This change could be reversed by enzymatic removal of
the a-mannosyl residues of RNase B, and the product, RNase
B’, returned to a half-life comparable to that of RNase A. These
observations clearly support the existence of a carbohydratespecific clearance process in the rat, which recognizes glycoproteins with terminal a-mannosyl residues.
The mechanism of this a-mannosyl-dependent
clearance
process has not yet been determined,
but the existence of a
plasma-binding
protein which could mediate the specific
clearance of RNase B has been excluded. The presence of such
a protein was considered unlikely in view of the rapid and
essentially identical clearance rates for all the RNase isozymes
through the kidney of the normal (un-nephrectomized)
rat
(Fig. 5). In addition, as mentioned previously, when RNase B
was mixed with serum or plasma, a binding protein was not
detectable through any inhibition of RNase activity on its high
molecular weight (yeast RNA) substrate; nor was the elution
volume of RNase B on Sephadex G-75 altered upon mixing
with serum or plasma. Thus it seems that, by analogy to the
clearance process described by Ashwell and Morel1 (2), the
clearance of RNase B probably occurs by way of a membranebinding protein, specific for the a-mannosyl residues of the
simple oligosaccharide;
and the list of carbohydrate-binding
proteins involved in these recognition processes in vertebrates
must be expanded from currently established fl-galactosyl- (2)
and /3-N-acetylglucosaminyl-binding
proteins (3) to include an
a-mannosyl-binding
protein as well.
The physiological function of this protein clearance mechanism is not known. It is interesting, however, to note that the
simple oligosaccharide,
containing
only mannose and Nacetylglucosamine,
is not a common component of plasma
glycoproteins. It is found in IgM (37) and IgE (38), and possibly
in IgA (39-41), but is apparently not present in IgG (42),
al-acid glycoprotein (43), a,-antitrypsin
(44), ceruloplasmin
(45), transferrin (46), or fetuin (47). Detailed information on
oligosaccharide
structures is unfortunately
not available for
the majority of the plasma proteins (e.g. ligand-binding
proteins, clotting factors, and complement proteins) so that a
true estimate of the frequency or distribution
of the simple
oligosaccharide
structures cannot be made. For the immunoglobulins,
IgM and IgE, the simple oligosaccharide
may
perform an important function. The fact that the immunoglobulins are relatively stable proteins in plasma suggests that-the
simple oligosaccharides
in these proteins are normally steritally protected from the sensing mechanism which rapidly
clears RNase B. (Perhaps the steric restriction explains why the
complex oligosaccharide was not synthesized on that site.) It is
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possible, then, that upon interaction with antigen, a conformational change in the antibody molecule could present the
simple oligosaccharide
to the environment,
resulting in the
clearance of the antibody.antigen
complex. Such a process
might be physiologically
important,
especially under conditions of antigen or antibody excess when macromolecular
aggregates may not be formed, e.g. during the initial or final
stages of an immune response. It is perhaps not a coincidence
that, in both IgM and IgE, the simple oligosaccharides
are
located at homologous sites in the Fc region of the heavy chain,
the region which is known to be involved in the disposition of
antibody subsequent to antigen binding. Other ligand-binding
proteins in plasma, which are rapidly cleared following complex formation, may also have simple oligosaccharides.
Thus,
for example hemoglobin. haptoglobin
(48, 49), heme. hemopexin (49), and protease.a,-macroglobulin
(50, 51) complexes
might be cleared in a manner similar to that proposed above
for some antigen.antibody
complexes.
The lysosomal glycosidases comprise a group of glycoproteins which are known to be rapidly cleared from the
circulation following intravenous injection (52254). And, while
the details of the carbohydrate structures of these enzymes are
not known, the limited information
on their binding
to
insolubilized
concanavalin A (55, 56) and their high mannose
content (57, 58) suggest that the removal of these enzymes
from the circulation
may be mediated by the a-mannosidedependent clearance process which we have described for
RNase B. In this respect, Stahl et al. (54) have reported that
the clearance of fi-glucuronidase is apparently not mediated by
liver receptors for asialo-(galactosyl-terminal)glycoproteins,
since asialofetuin and asialo-orosomucoid
failed to competitively inhibit the clearance of P-glucuronidase
from the rat
circulation. Thus it appears that, among other possibilities, the
cY-mannoside-dependent
clearance process may be involved in
regulating (i.e. limiting) the level of lysosomal enzymes in the
circulation, or may participate
in the transport of lysosomal
enzymes or other proteins between cells and organs within the
body.
In the above discussion, it has been tacitly assumed that the
process in which the a-mannosyl residues of RNase B are
recognized is directly exposed to the plasma compartment, and
that the removal of RNase B takes place directly from that
compartment. However, this is clearly not a necessary assumption in view of the rapid equilibration
of the RNase into the
extravascular compartment.
Indeed, the mannose recognition
and removal could occur equally well in either or both compartments. Future studies must be directed at establishing the organ specificity, the compartment location, and the physiological function of this clearance process.
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